Overview

Comparing Efficacy and Safety of TJO-083 in Dry Eye Disease Patients

Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
0
Participant gender:
All
Summary
This is a prospective randomized study compared with active control and placebo arms.
Phase:
Phase 1/Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Taejoon Pharmaceutical Co., Ltd.
Criteria
Inclusion Criteria:

- Male or female, age 20 or over

- Patient who have been diagnosed with dry eye syndrome at least 6 months ago

- Screening both eyes, the corrected visual acuity is 0.2 or more

- Written informed consent to participate in the trial

Exclusion Criteria:

- Screening visits within 2 months the patients with systemic or ocular disorders
affected the test results (ocular surgery, trauma, or disease)

- Intraocular pressure(IOP)> 21 mmHg